Alexandra Mancini
2021
In 2021, Alexandra Mancini earned a total compensation of $406.2K as Senior VP, Clinical & Regulatory Affairs at InMed Pharmaceuticals, a 32% increase compared to previous year.
Compensation breakdown
| Bonus | $84,788 |
|---|---|
| Option Awards | $69,083 |
| Salary | $252,346 |
| Total | $406,217 |
Mancini received $252.3K in salary, accounting for 62% of the total pay in 2021.
Mancini also received $84.8K in bonus and $69.1K in option awards.
Rankings
In 2021, Alexandra Mancini's compensation ranked 11,137th out of 12,415 executives tracked by ExecPay. In other words, Mancini earned more than 10.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,137 out of 12,415 | 10th |
Division Manufacturing | 4,918 out of 5,505 | 11th |
Major group Chemicals And Allied Products | 2,190 out of 2,375 | 8th |
Industry group Drugs | 1,949 out of 2,096 | 7th |
Industry Pharmaceutical Preparations | 1,445 out of 1,546 | 7th |
Source: SEC filing on October 28, 2021.
Mancini's colleagues
We found three more compensation records of executives who worked with Alexandra Mancini at InMed Pharmaceuticals in 2021.
News
InMed Pharmaceuticals CEO Eric Adams' 2024 pay rises 13% to $415K
October 28, 2024
InMed Pharmaceuticals CEO Eric Adams' 2023 pay falls 22% to $368K
October 27, 2023
InMed Pharmaceuticals CEO Eric Adams' 2022 pay falls 36% to $468K
October 28, 2022
InMed Pharmaceuticals CEO Eric Adams' 2021 pay jumps 73% to $735K
October 28, 2021